コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 Macular striae were seen in eyes with epiretinal membrane.
2 differentiate into myofibroblasts to form an epiretinal membrane.
3 d in 18 eyes (90%), and 14 eyes (75%) had an epiretinal membrane.
4 ic macular edema, retinal vein occlusion, or epiretinal membrane.
5 , vitreomacular interface abnormalities, and epiretinal membrane.
6 nal detachment at macula while the other, an epiretinal membrane.
7 tractive properties were termed conventional epiretinal membrane.
8 for FTMH width, vitreomacular adhesion, and epiretinal membrane.
9 cular pseudohole presented with conventional epiretinal membrane.
10 s with ocular pathologic features such as an epiretinal membrane.
11 logic features, primarily the presence of an epiretinal membrane.
12 opathy, 7 had retinal detachments, and 9 had epiretinal membranes.
13 promoted the development of dense, fibrotic epiretinal membranes.
14 as little or no HGFR was found in idiopathic epiretinal membranes.
15 oliferative vitreoretinopathy and idiopathic epiretinal membranes.
16 ysts, subretinal and intraretinal fluid, and epiretinal membranes.
17 ct the posterior hyaloid and widely adherent epiretinal membranes.
18 on and decreased alpha-SMA expression in the epiretinal membranes.
19 active properties than cells of conventional epiretinal membranes.
20 ommon complications were cataract (0.31/EY), epiretinal membrane (0.16/EY), and recurrent macular ede
21 interface disorders (either macular hole or epiretinal membrane), 1 patient had vitreous hemorrhage
23 38(14.0%).Of these patients,15(39.4%) had an epiretinal membrane,10(26.3%) had age-related macular de
24 echiae (21.7%), cystoid macular edema (16%), epiretinal membrane (13.2%), glaucoma (11.3%), increased
26 er were diagnosed in 52 out of 264 eyes with epiretinal membranes (19.7%), of which 28 (55.0%) had co
27 macular adhesion, vitreomacular traction, or epiretinal membrane; (3) presence, location, and amount
28 l subfield thicknesses were: eyes without an epiretinal membrane, 338 +/- 23 mum; and eyes with an ep
29 roliferative diabetic retinopathy (PDR) (5), epiretinal membrane (4), vitreomacular traction syndrome
30 s of PR included vitreous hemorrhage (9.1%), epiretinal membrane (45.17%), proliferative vitreoretino
31 ntraocular pressure (IOP); (7) macula pucker/epiretinal membrane; (8) cataract; and (9) quality of li
32 %), and all other baseline parameters except epiretinal membrane (84.3%), which was detected at a sig
33 ting for vitreoretinal diseases including an epiretinal membrane, age-related macular degeneration, v
34 (aHR, 1.43) and >/=2+ (aHR, 1.59) vs. none; epiretinal membrane (aHR, 1.25); peripheral anterior syn
36 inner nuclear layer in eyes with concomitant epiretinal membrane and glaucomatous optic neuropathy.
38 22-day delay, leading to significantly more epiretinal membrane and proliferative vitreoretinopathy
39 l membrane, 338 +/- 23 mum; and eyes with an epiretinal membrane and surface wrinkling, 405 +/- 22 mu
41 R) GUIDELINES: New evidence-based Idiopathic Epiretinal Membrane and Vitreomacular Traction Preferred
48 aretinal fluid, 4 eyes were found to have an epiretinal membrane, and 1 eye had optic nerve edema.
49 ma, retinal detachment, vitreous hemorrhage, epiretinal membrane, and band keratopathy), and visual o
51 , cataract, vitritis, cystoid macular edema, epiretinal membrane, and disc edema may occur in patient
52 hage at baseline, increasing age, absence of epiretinal membrane, and glycated hemoglobin below 9 as
53 lar edema, posterior capsular opacification, epiretinal membrane, and intraocular lens subluxation.
55 erwent pars plana vitrectomy, removal of any epiretinal membranes, and gas tamponade, with or without
56 opathy, ophthalmological lesions (cataracts, epiretinal membranes, and retinal hamartomas), and cutan
59 n of HGFR in human donor eyes and in several epiretinal membranes associated with proliferative vitre
60 n of HGFR in human donor eyes and in several epiretinal membranes associated with proliferative vitre
61 eadily detected in the cellular component of epiretinal membranes associated with PVR, whereas little
63 absence of foveal detachment, lamellar hole, epiretinal membrane, choroidal neovascularization, inner
68 e had a higher growth rate than eyes without epiretinal membrane (difference, 0.16; 95% CI, 0.03-0.30
70 res more frequently seen in uveitis included epiretinal membrane (ERM) (82.6% vs. 44.2%, p < 0.001),
73 5, 95% confidence interval [CI], 6.19-11.8), epiretinal membrane (ERM) (RR, 4.1, CI, 2.63-6.19), hist
75 cular traction (VMT), macular hole (MH), and epiretinal membrane (ERM) according to the International
76 in patients with macular pathologies such as epiretinal membrane (ERM) and could influence the result
79 00 (Carl Zeiss Meditech, Jena, Germany) with epiretinal membrane (ERM) and internal retinal membrane
83 selected among 369 patients examined for an epiretinal membrane (ERM) by Cirrus spectral-domain OCT
86 factors for cystoid macular edema (CME) and epiretinal membrane (ERM) development after surgery for
87 , or vehicle, and at appropriate time points epiretinal membrane (ERM) formation and retinal detachme
89 study was to study the prevalence of macular epiretinal membrane (ERM) formation for retinal tears tr
90 , the intraretinal glial response results in epiretinal membrane (ERM) formation, a proliferative and
91 cataract development, retinal redetachment, epiretinal membrane (ERM) formation, and single-surgery
93 osed a deep learning model that can identify epiretinal membrane (ERM) in OCT with ophthalmologist-le
94 (SRF) height, intraretinal cysts (IRC), and epiretinal membrane (ERM) on post-operative best-correct
95 ic lenses or contact lenses), a MIN lens, or epiretinal membrane (ERM) peeling (alone or in any combi
96 are functional and anatomical outcomes after epiretinal membrane (ERM) peeling with internal limiting
98 ne (ILM) peeling after idiopathic unilateral epiretinal membrane (ERM) removal and to compare outcome
99 ing the postoperative outcomes of idiopathic epiretinal membrane (ERM) surgery based on preoperative
100 of exogenous cells into the vitreous to form epiretinal membrane (ERM) which does not recapitulate a
101 e and clinical associations of patients with epiretinal membrane (ERM) who develop central-peripheral
102 (PPV): 6 for vitreous hemorrhage (VH), 1 for epiretinal membrane (ERM), and an additional 8 for tract
103 criteria included FTMH >400 mum, presence of epiretinal membrane (ERM), and aphakia in the study eye.
104 eter and presence of vitreomacular traction, epiretinal membrane (ERM), and cystoid macular edema (CM
105 ndergoing pars plana vitrectomy to remove an epiretinal membrane (ERM), and test subjects (n = 7) wit
106 esolution of CME, OCT characteristics of CME/epiretinal membrane (ERM), type of surgery, and treatmen
107 reous fluids were obtained from 19 eyes with epiretinal membrane (ERM), which were used as control sa
116 , and fibroblasts (the cell types crucial in epiretinal membrane [ERM] formation) under identical mic
117 ectopic inner foveal layers associated with epiretinal membranes (ERMs) and to present a new optical
118 The development of symptoms in patients with epiretinal membranes (ERMs) often corresponds with the a
121 n younger patients (<65 years), eyes without epiretinal membrane, eyes with FTMH, phakic eyes, and ey
122 ing/other changes, macular atrophy/puckering/epiretinal membranes, FAF findings such as a central hyp
124 ), whereas hypotony (3% vs. 13%, P = 0.038), epiretinal membrane formation (2% vs. 8%; P = 0.028), an
127 CI = 2.00-3.59, P < .001), and in eyes with epiretinal membrane formation (hazard ratio = 1.54, 95%
128 r edema (RR, 0.47 [0.25-0.88]; P = 0.02) and epiretinal membrane formation (RR, 0.70 [0.52-0.94]; P =
130 sue formation at the disc area as well as an epiretinal membrane formation, for which she had pars pl
131 cluding postoperative cystoid macular edema, epiretinal membrane formation, macular folds, and, ultim
133 ces (ECM) is important in the development of epiretinal membranes found in proliferative vitreoretino
135 cular interface pathology such as idiopathic epiretinal membrane (iERM) (n = 4), vitreomacular tracti
136 ence of progression to surgery on idiopathic epiretinal membrane (iERM) and compared the results with
137 flammation in the pathogenesis of idiopathic epiretinal membrane (iERM) by evaluating blood-count-der
138 ile of cells growing out of human idiopathic epiretinal membranes (iERMs) and testing their prolifera
140 native internal limiting membrane in 2 eyes, epiretinal membrane in 1 eye, and remnant cortical vitre
141 8 eyes (29%) and 6 eyes (38%) (P = .34), and epiretinal membrane in 5 eyes (20.8%) and 4 eyes (25%) (
147 pathy, retinal vein occlusion, macular hole, epiretinal membrane, macular degeneration, retinal detac
148 cal changes in OCT in the macular region, as epiretinal membrane, macular edema, subretinal fluid or
149 e diabetic retinopathy, and the other 13 for epiretinal membrane, macular hole, vitreous opacities, o
150 ssing the presence of cystoid macular edema, epiretinal membrane, macular holes, and external limitin
153 n of the retinal inner layers (DRIL), cysts, epiretinal membranes, microaneurysms, subretinal fluid,
154 ), optic nerve abnormalities (n = 2 [1.9%]), epiretinal membrane (n = 2 [1.9%]), and drusen (n = 2 [1
156 fluid (n = 6), subretinal exudation (n = 6), epiretinal membrane (n = 3), retinal hemorrhage (n = 2),
157 s" at distance and/or for reading) caused by epiretinal membrane (n = 44) or other retinal disorders
158 cyclitic membrane (n = 18, 69%), neoplastic epiretinal membrane (n = 6, 23%), and persistent hyaloid
159 he RPE monolayer in human donor eyes, and in epiretinal membranes obtained from patients with PVR.
162 eptors (PDGFRs) are present and activated in epiretinal membranes of patient donors, and they are ess
169 ionally underwent pars plana vitrectomy with epiretinal membrane or ILM peel within 1 month of random
171 naive wet AMD group (group 3, n = 10) and an epiretinal membrane or macular hole group (group 4, n =
173 surgery involves pars plana vitrectomy with epiretinal membrane or proliferation and internal limiti
174 lysis of patients with a diagnosis of either epiretinal membrane or vitreous opacities, there was no
175 es of visual loss such as SO emulsification, epiretinal membranes or macular edema were excluded.
176 016, 152,034 macular surgical procedures for epiretinal membranes or macular holes were recorded in F
177 .75; 95% CI, 0.68-0.82), and macular hole or epiretinal membrane (OR, 0.55; 95% CI, 0.48-0.65) were l
179 baseline VA (P < 0.001), the presence of an epiretinal membrane (P = 0.03), and the peeling of the i
180 < 0.001), but remained stable after PPV for epiretinal membrane (p = 0.555), macular hole (p = 0.695
181 3 months (20/94 vs 20/35 for eyes without an epiretinal membrane, P = .002) and at 6 months follow-up
183 one oil removal in one patient, and combined epiretinal membrane peeling and silicone oil removal in
184 ma (PRB 28%, PR 39%, PFCL 46%, P = .003) and epiretinal membrane (PRB 64%, PR 90%, PFCL 61%, P < .001
185 ed include central subfield thickness (CST), epiretinal membrane presence, intraretinal and subretina
186 epiretinal proliferation, whereas tractional epiretinal membranes presenting contractive properties w
187 p visits revealed regressed mMNV with a taut epiretinal membrane, progressive worsening of outer MRS,
188 etinal Defect Associated With High Myopia or Epiretinal Membrane," published online January 22, 2015,
189 patients in the single-peeling group had an epiretinal membrane remaining in the central fovea posto
191 ucoma, age-related macular degeneration, and epiretinal membrane, require specific considerations for
192 These conditions include macular holes, epiretinal membranes, retinal detachments, and retinopat
194 al [CI], 1.57-4.34), a previous diagnosis of epiretinal membrane (RR, 5.60; 95% CI, 3.45-9.07), uveit
195 ted internal limiting membrane specimens and epiretinal membrane specimens removed from 25 eyes of 25
197 inal detachment was 2.37% overall, 1.95% for epiretinal membrane surgery, and 3.43% for macular hole
199 iferation is a distinct clinical entity from epiretinal membrane that classically is associated with
202 retinoschisis, myopic traction maculopathy, epiretinal membrane, vitreoretinal traction, optic or sc
205 fects of "single peeling," in which only the epiretinal membrane was peeled, and "double peeling," in
206 embrane was removed in 25.7% (143 eyes), and epiretinal membrane was removed in 18.3% (102 eyes).
208 ative vitreoretinopathy (PVR) and idiopathic epiretinal membranes was analyzed by immunohistochemistr
216 er nuclear layer in patients with idiopathic epiretinal membranes, with and without glaucomatous opti
217 Eyes without epiretinal membranes and with epiretinal membranes without surface wrinkling were not